GlassScriptPhysician profile
Gary S Shapiro
NPI 1881649689
$5,929.06
in general payments reported to CMS, 2019-2025
19 companies · $123 in 2025
The $123 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,301 · 2020: $558 · 2021: $287 · 2022: $160 · 2023: $1,340 · 2024: $161 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,200 · Food and Beverage: $424.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,200.00 |
| Food and Beverage | $424.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $2,266.42 | 2019 | |
| Arthrex, INC. | $1,340.19 | 2023 | Spine Instruments Endoscopic Instrument Sets |
| Stryker Corporation | $573.30 | 2019 | |
| Surgalign Spine Technologies, INC. | $478.03 | 2019-2020 | |
| Centinel Spine, LLC | $343.50 | 2019-2021 | |
| Sanara Medtech INC. | $175.78 | 2021-2022 | |
| Depuy Synthes Sales INC. | $141.88 | 2020-2025 | Expedium, Synfix Evolution, Acis Proti 360 Hl |
| Medtronic, INC. | $124.11 | 2021-2024 | Capstone Ptc Spinal System |
| Orthofix Medical, INC. | $118.72 | 2019-2020 | |
| Si-Bone, INC. | $113.42 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $46.44 | 2024 | Exparel |
| Ferring Pharmaceuticals INC. | $45.33 | 2025 | Euflexxa |
| Abbvie INC. | $43.76 | 2019-2025 | |
| Pfizer INC. | $37.11 | 2022 | |
| Nuvasive, INC. | $35.82 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $20.07 | 2019 | |
| Collegium Pharmaceutical, INC. | $19.18 | 2021 | |
| Biocomposites INC | $6.00 | 2025 | Stimulan |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$111,759.56 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Shapiro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.